RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
RT @DanCiccarone: Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same…
Rebound risk for opioid overdose is a known risk for folks coming off oral natrexone. A study out today suggests the same for extended release naltrexone (Vivitrol). https://t.co/1z2bgq6Zaz
RT @ADAWnews: "We also urge greater scrutiny of sponsor claims of no connection between Vivitrol and overdose in the case narratives....the…
RT @maiasz: this was one of the key concerns that spurred this reporting https://t.co/FAKVpg7EVf https://t.co/UgdPj7ir5y
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
RT @maiasz: this was one of the key concerns that spurred this reporting https://t.co/FAKVpg7EVf https://t.co/UgdPj7ir5y
RT @maiasz: this was one of the key concerns that spurred this reporting https://t.co/FAKVpg7EVf https://t.co/UgdPj7ir5y
this was one of the key concerns that spurred this reporting https://t.co/FAKVpg7EVf https://t.co/UgdPj7ir5y
RT @ADAWnews: "We also urge greater scrutiny of sponsor claims of no connection between Vivitrol and overdose in the case narratives....the…
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
"We also urge greater scrutiny of sponsor claims of no connection between Vivitrol and overdose in the case narratives....the sponsor gave one of two (some-times both) rote statements in three-quarters of overdose death reports, each disavowing connection
RT @LeoBeletsky: BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts give…
BREAKING: new data analyzing FDA adverse event case reports raises further concerns about "rebound" OD risk among pts given Vivitrol injections to treat opioid use disorder https://t.co/XJAXtfDJEP #drugsafety #druglaw